1-20 of 325898
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal: Blood
Blood (2025) 146 (20): 2374–2375.
Published: 2025
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal: Blood
Blood (2025) 146 (20): 2382–2383.
Published: 2025
Journal Articles
Images
Activation of FXR in hepatocytes by bile acids or tropifexor downregulates expression of Serpine 1, the gene that encodes PAI-1. This results in decreased plasma levels of PAI-1 and enhancement of fibrin-clot lysis. Professional illustration by Patrick Lane, ScEYEnce Studios.
Published: 2025
Activation of FXR in hepatocytes by bile acids or tropifexor downregulates expression of Serpine 1 , the gene that encodes PAI-1. This results in decreased plasma levels of PAI-1 and enhancement of fibrin-clot lysis. Professional illustration by Patrick Lane, ScEYEnce Studios. More about this image found in Activation of FXR in hepatocytes by bile acids or tropifexor downregulates ...
Images
In vivo efficacy of IC488743 treatment of human MM xenografts in SCID mice. (A) Mice injected with 5 × 106 LB cells were treated orally twice a day with control vehicle (●), and IC488743 10 mg/kg ( □ ) or 30 mg/kg (○). Mean tumor volume was calculated as in “Murine xenograft models of human MM.” Error bars represent SD. (B) Representative whole-body images from a mouse treated for 12 days with control vehicle (top panel) or IC488743 (30 mg/kg; bottom panel). (C) Tumors harvested from IC488743 (30 mg/kg) treated mouse (right panel) and control mouse (left panel) were subjected to immunohistochemical analysis using CD31 and P-AKT Abs. CD31 and P-AKT positive cells are dark brown. (D) Mice were treated with IC488743 10 mg/kg (hyphenated line), 30 mg/kg (dotted line), or control vehicle (solid line). Survival was evaluated from the first day of treatment until death using Kaplan-Meier curves. (E) Tumor tissues were harvested from mice treated with control vehicle or IC488743 (30 mg/kg). Protein levels of phosphorylated of PDK-1 and AKT (Ser473) were determined by Western blotting of cell lysates. Actin was used as a loading control. (F) Growth of INA-6 cells engrafted in human bone chips in SCID mice was monitored by serial serum measurements of shuIL-6R. Mice were treated with IC488743 10 mg/kg ( □ ), 30 mg/kg ( △ ), or control vehicle (●), and shuIL-6R levels were determined weekly by ELISA. Error bars represent SD.
Published: 2025
Figure 6. In vivo efficacy of IC488743 treatment of human MM xenografts in SCID mice. (A) Mice injected with 5 × 10 6 LB cells were treated orally twice a day with control vehicle (●), and IC488743 10 mg/kg ( □ ) or 30 mg/kg (○). Mean tumor volume was calculated as in “Murine xenograft models o... More about this image found in In vivo efficacy of IC488743 treatment of human MM xenografts in SCID mice....
Journal Articles
Journal Articles
Journal Articles